A recent study has shown that CA’s inhibitory effects on MMP-2 and MMP-9 are linked to its ability to block NF-κB activation, thereby reducing tumor development and spread in hepatocellular carcinoma cancer cells (HCC) [152]. The gene discussed is NFKB1; the disease is neoplasm.